Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Periodic tryptophan protein 1 homolog (PWP1) is a nuclear, chromatin-associated protein characterized by WD-40 repeats that regulate transcriptional processes. It is integral to rRNA biogenesis mediated by RNA polymerase I, controls the epigenetic status of ribosomal DNA, and is implicated in the regulation of cell cycle–dependent transcriptional events. PWP1 expression is upregulated in certain cancers, including pancreatic adenocarcinoma, and is associated with disease such as adenocarcinoma and porokeratosis. PWP1 is not currently classified as a receptor, enzyme, or therapeutic target and has no approved interacting drugs, mechanisms of drug action, or established biomarker or safety roles[2][6][8][4][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Periodic tryptophan protein 1 homolog (PWP1).